MYOS MYOS RENS Technology Inc

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Walgreens Boots Alliance, Inc. (NASDAQ:WBA), Altice USA, Inc. (NYSE:ATUS), Fortuna Silver Mines Inc. (NYSE:FSM), Marathon Petroleum Corporation (NYSE:MPC), Endologix, Inc. (NASDAQ:ELGX), and MYOS RENS Technology Inc. (NASDAQ:MYOS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

WBA DOWNLOAD: http://Capital-Review.com/register/?so=WBA ATUS DOWNLOAD: http://Capital-Review.com/register/?so=ATUS FSM DOWNLOAD: http://Capital-Review.com/register/?so=FSM MPC DOWNLOAD: http://Capital-Review.com/register/?so=MPC ELGX DOWNLOAD: http://Capital-Review.com/register/?so=ELGX MYOS DOWNLOAD: http://Capital-Review.com/register/?so=MYOS

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine Walgreens Boots Alliance, Inc. (NASDAQ:WBA), Altice USA, Inc. (NYSE:ATUS), Fortuna Silver Mines Inc. (NYSE:FSM), Marathon Petroleum Corporation (NYSE:MPC), Endologix, Inc. (NASDAQ:ELGX), and MYOS RENS Technology Inc. (NASDAQ:MYOS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

WALGREENS BOOTS ALLIANCE, INC. (WBA) REPORT OVERVIEW

Walgreens Boots Alliance's Recent Financial Performance

For the three months ended February 28th, 2019 vs February 28th, 2018, Walgreens Boots Alliance reported revenue of $34,528.00MM vs $33,021.00MM (up 4.56%) and analysts estimated basic earnings per share $1.25 vs $1.36 (down 8.09%). For the twelve months ended August 31st, 2018 vs August 31st, 2017, Walgreens Boots Alliance reported revenue of $131,537.00MM vs $118,214.00MM (up 11.27%) and analysts estimated basic earnings per share $5.07 vs $3.80 (up 33.42%). Analysts expect earnings to be released on June 27th, 2019. The report will be for the fiscal period ending May 31st, 2019. The reported EPS for the same quarter last year was $1.53. The estimated EPS forecast for the next fiscal year is $6.01 and is expected to report on October 10th, 2019.

To read the full Walgreens Boots Alliance, Inc. (WBA) report, download it here: http://Capital-Review.com/register/?so=WBA

-----------------------------------------

ALTICE USA, INC. (ATUS) REPORT OVERVIEW

Altice's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Altice reported revenue of $2,454.94MM vs $2,359.81MM (up 4.03%) and analysts estimated basic earnings per share $0.29 vs $3.26 (down 91.10%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Altice reported revenue of $9,566.61MM vs $9,306.95MM (up 2.79%) and analysts estimated basic earnings per share $0.03 vs $2.15 (down 98.60%). Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is $0.91 and is expected to report on February 20th, 2020.

To read the full Altice USA, Inc. (ATUS) report, download it here: http://Capital-Review.com/register/?so=ATUS

-----------------------------------------

FORTUNA SILVER MINES INC. (FSM) REPORT OVERVIEW

Fortuna Silver Mines' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Fortuna Silver Mines reported revenue of $59.59MM vs $75.35MM (down 20.92%) and analysts estimated basic earnings per share $0.01 vs $0.22 (down 95.45%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Fortuna Silver Mines reported revenue of $263.30MM vs $268.11MM (down 1.80%) and analysts estimated basic earnings per share $0.21 vs $0.42 (down 50.00%). Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.09. The estimated EPS forecast for the next fiscal year is $0.42 and is expected to report on March 11th, 2020.

To read the full Fortuna Silver Mines Inc. (FSM) report, download it here: http://Capital-Review.com/register/?so=FSM

-----------------------------------------

MARATHON PETROLEUM CORPORATION (MPC) REPORT OVERVIEW

Marathon Petroleum's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Marathon Petroleum reported revenue of $32,333.00MM vs $21,055.00MM (up 53.56%) and basic earnings per share $1.35 vs $3.97 (down 65.99%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Marathon Petroleum reported revenue of $96,504.00MM vs $74,733.00MM (up 29.13%) and analysts estimated basic earnings per share $5.36 vs $6.76 (down 20.71%). Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for the next fiscal year is $9.09 and is expected to report on February 6th, 2020.

To read the full Marathon Petroleum Corporation (MPC) report, download it here: http://Capital-Review.com/register/?so=MPC

-----------------------------------------

ENDOLOGIX, INC. (ELGX) REPORT OVERVIEW

Endologix's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Endologix reported revenue of $34.69MM vs $44.00MM (down 21.16%) and analysts estimated basic earnings per share -$2.67 vs -$1.67. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Endologix reported revenue of $156.47MM vs $181.16MM (down 13.63%) and analysts estimated basic earnings per share -$9.07 vs -$7.97. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$1.60. The estimated EPS forecast for the next fiscal year is -$4.12 and is expected to report on February 24th, 2020.

To read the full Endologix, Inc. (ELGX) report, download it here: http://Capital-Review.com/register/?so=ELGX

-----------------------------------------

MYOS RENS TECHNOLOGY INC. (MYOS) REPORT OVERVIEW

MYOS RENS Technology's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, MYOS RENS Technology reported revenue of $0.15MM vs $0.16MM (down 5.10%) and analysts estimated basic earnings per share $0.00 vs -$0.17. For the twelve months ended December 31st, 2018 vs December 31st, 2017, MYOS RENS Technology reported revenue of $0.36MM vs $0.53MM (down 31.56%) and analysts estimated basic earnings per share -$0.45 vs -$0.69. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is -$0.54 and is expected to report on March 26th, 2020.

To read the full MYOS RENS Technology Inc. (MYOS) report, download it here: http://Capital-Review.com/register/?so=MYOS

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Morena Zambada, Media Department Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.